Federal award
TENAX THERAPEUTICS, INC.
W81XWH1120122
Assistance
Obligated and Ceiling
- Obligated (net)
- $1,877,955.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $2,184,949.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TENAX THERAPEUTICS, INC. · N5YWD27TA8U6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TENAX THERAPEUTICS, INC. · N5YWD27TA8U6
- Awarding agency
- Department of Defense · sub-agency 9700
- Funding agency
- —
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH1120122
- Award type code
- 05
- Actions
- 5 · Mar 1, 2011 to Sep 19, 2016
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 19, 2016 | FY2016 | 0005 | FX | $109,802.00 | — |
| Sep 16, 2016 | FY2016 | 0004 | FX | −$306,994.00 | — |
| Jul 23, 2014 | FY2014 | 0003 | EX | $0.00 | — |
| Jun 28, 2013 | FY2013 | 0002 | EX | $0.00 | — |
| Mar 1, 2011 | FY2011 | — | A1 | $2,075,147.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.